Full Text
Cost-Effectiveness of Ibrutinib in Adult Patients with Relapsed Chronic Lymphocytic Leukaemia in the Netherlands

Abstract

Authors

H Welten TJ Ignacio BG Verheggen

Back to Volume 19, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×